A Texas Patient & Provider Resource

Understanding SPRAVATO® treatment in Texas.

Clear, independent information about SPRAVATO® (esketamine) — an FDA-approved nasal spray for adults with treatment-resistant depression. Find certified clinics, understand the pharmacy process, and navigate insurance in Texas.

The basics

What is SPRAVATO®?

SPRAVATO® (esketamine) is a prescription nasal spray and a Schedule III controlled substance, manufactured by Janssen (a Johnson & Johnson company).

Esketamine is the S-enantiomer of ketamine — a distinct, separately FDA-approved medication. It is a non-competitive NMDA-receptor antagonist, a fundamentally different mechanism than traditional oral antidepressants, and is considered rapid-acting (improvement was seen as early as 24 hours in clinical trials).

SPRAVATO® is not the same as ketamine and is administered only in certified healthcare settings under the FDA's REMS program.

FDA-approved uses

What it's approved to treat

Indication 1

Treatment-Resistant Depression (TRD)

In adults — as monotherapy or in conjunction with an oral antidepressant. TRD generally means inadequate response to at least two antidepressants in the current episode.

Indication 2

MDD with Acute Suicidal Ideation or Behavior

Depressive symptoms in adults with major depressive disorder (MDD) who have acute suicidal ideation or behavior — in conjunction with an oral antidepressant.

Limitations of use: SPRAVATO® is not approved as an anesthetic. Effectiveness in preventing suicide or reducing suicidal ideation or behavior has not been demonstrated. Not approved for pediatric use.

Rapid-acting

Improvement seen as early as 24 hours in clinical trials.

In-clinic only

Administered exclusively in REMS-certified healthcare settings.

Not at retail

Cannot be picked up at a pharmacy or taken home.

New in 2025

FDA approved SPRAVATO® as the first standalone (monotherapy) treatment for treatment-resistant depression.

Previously approved only as an add-on to an oral antidepressant for TRD, the January 2025 approval allows SPRAVATO® to be used on its own — a meaningful option for patients who can't tolerate additional oral antidepressants.

Statewide coverage

SPRAVATO® treatment across Texas

From Houston, Dallas–Fort Worth, Austin and San Antonio to El Paso, the Panhandle, the Permian Basin, the Rio Grande Valley and East Texas — explore an interactive map of 60+ verified SPRAVATO® clinic listings across 20+ Texas cities.

Open the full map →
1Amarillo1Lubbock6El Paso1Midland–Odessa1Plano5Dallas5Fort Worth4Tyler–Longview2Killeen7Austin2College Station / Bryan7San Antonio11Houston1Beaumont2Corpus Christi3Rio Grande Valley
Certified SPRAVATO® clinic locationSome metros have multiple clinics — number on each pin = clinics in that area. Hover or tap a pin for the list.

Explore the guide

Ready to find a certified clinic?

Browse 60+ REMS-certified SPRAVATO® clinic listings across 20+ Texas cities — from Houston, Dallas and Austin to El Paso, the Rio Grande Valley and East Texas.

Browse Texas clinics

If you're in crisis, call or text 988 — the Suicide & Crisis Lifeline.